选择偏倚对检测阴性研究中疫苗有效性估计值的影响
该研究通过模拟和观察性数据分析,探讨检测阴性研究中选择偏倚对流感疫苗有效性(VE)估计的影响。模拟显示仅当流感急性呼吸道感染(ARI)与非流感ARI的就医率差异极大时,选择偏倚才有意义;观察性研究中未校正VE为55%(95%CI 47-62%),校正后为57%(95%CI 49-63%),差异微小。结论认为实际条件下选择偏倚不太可能具有实际意义。
要点
- 模拟显示选择偏倚仅在流感与非流感ARI就医率差异极大时才有意义。
- 观察性研究中未校正VE为55%(95%CI 47-62%),校正后为57%(95%CI 49-63%)。
- 实际条件下检测阴性研究的选择偏倚不太可能具有实际意义。
核心结论
- 检测阴性VE研究中选择偏倚虽可能存在,但在实际可能遇到的条件下不太可能具有实际意义。
- 研究人员和公共卫生官员可以继续依赖检测阴性研究的VE估计值。
研究设计与样本
- 模拟研究:定义了一个假想人群,其成员有因流感和其他病原体发生急性呼吸道感染(ARI)的风险,未测量的就医倾向同时影响接种疫苗和因ARI就医的概率。
- 观察性研究:重新分析了美国流感VE网络(一项正在进行的检测阴性研究)的数据,比较未校正VE估计与使用源人群数据校正抽样偏倚后的VE估计。
主要发现
- 模拟研究:若流感ARI患者比非流感ARI患者更可能或更不可能就医,未测量的就医倾向可产生选择偏倚;但仅当两者就医率差异极大时选择偏倚才有意义。
- 观察性研究:未校正VE估计为55%(95%CI 47-62%),校正后VE估计为57%(95%CI 49-63%),两者差异微小。
临床怎么用
- 研究人员和公共卫生官员可以继续依赖检测阴性研究的VE估计值。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Estimates of vaccine effectiveness (VE) from test-negative studies may be subject to selection bias. In the context of influenza VE, we used simulations to identify situations in which meaningful selection bias can occur. We also analyzed observational study data for evidence of selection bias. METHODS: For the simulation study, we defined a hypothetical population whose members are at risk for acute respiratory illness (ARI) due to influenza and other pathogens. An unmeasured "healthcare seeking proclivity" affects both probability of vaccination and probability of seeking care for an ARI. We varied the direction and magnitude of these effects and identified situations where meaningful bias occurred. For the observational study, we reanalyzed data from the United States Influenza VE Network, an ongoing test-negative study. We compared "bias-naïve" VE estimates to bias-adjusted estimates, which used data from the source populations to correct for sampling bias. RESULTS: In the simulation study, an unmeasured care-seeking proclivity could create selection bias if persons with influenza ARI were more (or less) likely to seek care than persons with non-influenza ARI. However, selection bias was only meaningful when rates of care seeking between influenza ARI and non-influenza ARI were very different. In the observational study, the bias-naïve VE estimate of 55% (95% CI, 47--62%) was trivially different from the bias-adjusted VE estimate of 57% (95% CI, 49--63%). CONCLUSIONS: In combination, these studies suggest that while selection bias is possible in test-negative VE studies, this bias in unlikely to be meaningful under conditions likely to be encountered in practice. Researchers and public health officials can continue to rely on VE estimates from test-negative studies.
引用
- Jackson ML, Phillips CH, Benoit J, et al. The impact of selection bias on vaccine effectiveness estimates from test-negative studies. Vaccine. 2017. PMID: 29254838. doi:10.1016/j.vaccine.2017.12.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。